CopyMark Law Group
4.9/5
Drawing for CPIC

USPTO serial 86783886

CPIC

Reviewed by CopyMark Law Group

Reg. 4972554Status 702Renewal
Filing date
Status date
Registration date
Jun 7, 2016
Examiner
FIONDA, LAURA ELIZABETH
Law office
TMEG LAW OFFICE 108

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CPIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,700

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angela Y. Dai

Angela Y. Dai Office Of The General Counsel31 Center DriveBldg. 31 Suite 2B-50Bethesda, MD 20892-0001

Goods and services

ClassDescriptionStatusFirst use
035Association services, namely, organization of a consortium for the purpose of optimization of drug therapy results in the treatment of human diseases based on genetic information; promoting collaboration within the biomedical research communities to develop and achieve improved drug therapy results based on genetic information and providing related information about opportunities to participate in such research; promoting the interests of the biomedical research communities by organizing groups and partnerships for the purpose of optimization of drug therapy results in the treatment of human diseases based on genetic informationACTIVE—
042Development of peer-reviewed guidelines to optimize drug therapy results based on genetic information; scientific research for medical purposes in the field of pharmacogenomicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 8, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 8, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 8, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 5, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jun 7, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 7, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 22, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 22, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 2, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2016DOCKASSIGNED TO EXAMINER—
Oct 16, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance